» Articles » PMID: 33006554

Important Tools for Use by Pediatric Endocrinologists in the Assessment of Short Stature

Overview
Date 2020 Oct 2
PMID 33006554
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Assessment and management of children with growth failure has improved greatly over recent years. However, there remains a strong potential for further improvements by using novel digital techniques. A panel of experts discussed developments in digitalization of a number of important tools used by pediatric endocrinologists at the third 360° European Meeting on Growth and Endocrine Disorders, funded by Merck KGaA, Germany, and this review is based on those discussions. It was reported that electronic monitoring and new algorithms have been devised that are providing more sensitive referral for short stature. In addition, computer programs have improved ways in which diagnoses are coded for use by various groups including healthcare providers and government health systems. Innovative cranial imaging techniques have been devised that are considered safer than using gadolinium contrast agents and are also more sensitive and accurate. Deep-learning neural networks are changing the way that bone age and bone health are assessed, which are more objective than standard methodologies. Models for prediction of growth response to growth hormone (GH) treatment are being improved by applying novel artificial intelligence methods that can identify non-linear and linear factors that relate to response, providing more accurate predictions. Determination and interpretation of insulin-like growth factor-1 (IGF-1) levels are becoming more standardized and consistent, for evaluation across different patient groups, and computer-learning models indicate that baseline IGF-1 standard deviation score is among the most important indicators of GH therapy response. While physicians involved in child growth and treatment of disorders resulting in growth failure need to be aware of, and keep abreast of, these latest developments, treatment decisions and management should continue to be based on clinical decisions. New digital technologies and advancements in the field should be aimed at improving clinical decisions, making greater standardization of assessment and facilitating patient-centered approaches.

Citing Articles

Which method is more effective in predicting adult height in pubertal girls treated with gonadotropin-releasing hormone agonist?.

Kagizmanli G, Sevim R, Besci O, Yuksek Acinikli K, Buran A, Erbas I Hormones (Athens). 2023; 22(3):501-506.

PMID: 37436638 DOI: 10.1007/s42000-023-00466-2.


Accelerating digital health literacy for the treatment of growth disorders: The impact of a massive open online course.

Dimitri P, Fernandez-Luque L, Koledova E, Malwade S, Syed-Abdul S Front Public Health. 2023; 11:1043584.

PMID: 37143968 PMC: 10151751. DOI: 10.3389/fpubh.2023.1043584.


Integrated Digital Health Solutions in the Management of Growth Disorders in Pediatric Patients Receiving Growth Hormone Therapy: A Retrospective Analysis.

Tornincasa V, Dixon D, Le Masne Q, Martin B, Arnaud L, van Dommelen P Front Endocrinol (Lausanne). 2022; 13:882192.

PMID: 35846336 PMC: 9281444. DOI: 10.3389/fendo.2022.882192.


Automated growth monitoring app (GROWIN): a mobile Health (mHealth) tool to improve the diagnosis and early management of growth and nutritional disorders in childhood.

De Arriba Munoz A, Garcia Castellanos M, Cajal M, Beisti Ortego A, Ruiz I, Labarta Aizpun J J Am Med Inform Assoc. 2022; 29(9):1508-1517.

PMID: 35799406 PMC: 9382383. DOI: 10.1093/jamia/ocac108.

References
1.
Clemmons D . Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem. 2011; 57(4):555-9. DOI: 10.1373/clinchem.2010.150631. View

2.
Tanaka A, Masumoto T, Yamada H, Kurauchi M, Breuer J . A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System. Magn Reson Med Sci. 2015; 15(2):227-36. PMC: 5600060. DOI: 10.2463/mrms.mp.2015-0083. View

3.
Saari A, Sankilampi U, Hannila M, Saha M, Makitie O, Dunkel L . Screening of turner syndrome with novel auxological criteria facilitates early diagnosis. J Clin Endocrinol Metab. 2012; 97(11):E2125-32. DOI: 10.1210/jc.2012-1739. View

4.
Blum W, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E . The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 2018; 7(6):R212-R222. PMC: 5987361. DOI: 10.1530/EC-18-0099. View

5.
Di Iorgi N, Secco A, Napoli F, Tinelli C, Calcagno A, Fratangeli N . Deterioration of growth hormone (GH) response and anterior pituitary function in young adults with childhood-onset GH deficiency and ectopic posterior pituitary: a two-year prospective follow-up study. J Clin Endocrinol Metab. 2007; 92(10):3875-84. DOI: 10.1210/jc.2007-1081. View